- Oxford Clinical Trials Research Unit Research Group
OCTRU Head of Programming
I have over 25 years’ experience in the IT industry, working in manufacturing, finance, telecommunications and the public sector before working in Clinical Trials when I joined the Oncology Clinical Trials Office (OCTO) in 2004.
I am OCTRU's Head of Programming and lead a team of 5 programmers/database officers. I joined OCTRU in October 2013 when we had no IT systems to speak of. Since then we have developed 5 systems and installed and support 4 off-the-shelf systems.
We look forward to taking these systems forward and to continue providing a responsive and professional service to all the Clinical Trials Units within the OCTRU family.
Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 - 1557
Rosmarin D. et al, (2015), Gut, 64, 111 - 120
Dutton SJ. et al, (2014), Lancet Oncol, 15, 894 - 904
Rosmarin D. et al, (2014), J Clin Oncol, 32, 1031 - 1039
Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.
Nicum S. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31